Tech stocks, once highfliers, drop; Nasdaq sinks

Tuesday, 29 April 2014 06:32
The tech-heavy Nasdaq composite plunged 110 points, or 2.6 percent, to 4,127, its biggest drop in two months. Other major indexes fell, but not nearly as much. The S&P 500 index fell 23 points, or 1.3 percent, to 1,865. The index traded at an all-time high earlier in the day. The Dow Jones industrial average lost 159 points, or 1 percent, to 16,412.
MARKET PULSE-Hugoton, Zhone, Unisys, Sodastream, Boeing, Delta
Wednesday, 23 April 2014 13:45
(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s) April 23 (Reuters) - U.S. stocks declined on Wednesday after a six-session winningstreak as gains in Boeing (NYSE: BA - news) and Gilead were offset by slides inAT&T (NYSE: T - news) and the wider biotech sector.
Louisiana offers business-friendly environment for growing industries
Monday, 21 April 2014 10:30
Louisiana ranks in the top five in the nation in several business categories and sixth overall among the top states to do business. In a recent issue of the magazine Area Development, the state scored an impressive seven top five rankings. Related 6 Picks for your weekend entertainmentWorkforce training center underway in.
Jim Cramer's 'Mad Money' Recap: Good-News Monday
Monday, 14 April 2014 18:33
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- For once, the late-day rally held into the close, Jim Cramer said on Mad Money Monday. That's good news for the bulls because both growth and value stocks were able to both rally on the same day. Cramer said there have been many sectors of the market struggling of late.
Dimension Therapeutics Expands Leadership Team and Scientific Advisory Board with Key Appointments
Monday, 14 April 2014 07:45
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Dimension Therapeutics, a gene therapy company focused on developing novel treatments for rare diseases, today announced the appointments of K. Reed Clark, Ph.D. to the newly created position of vice president, manufacturing and Terrence R. Flotte, M.D., Celia and Isaac Haidak Professor in Medical Education, dean of the School of Medicine and provost and executive deputy chancellor of the University of Massachusetts Medical School (UMMS) to the company’s scientific advisory board.
Market Wrap For April 11: Markets Pick Up Exactly Where They Left Off
Sunday, 13 April 2014 22:45
View photo. U.S. stocks declined sharply for the second day in a row as investors found little reason to reverse Thursday's bullish activity. Right off the bat, JPMorgan reported disappointing quarterly results which led to a decline in the S&P 500 index. The Volatility Index, also known as the "fear index" rose 6.7 percent to 16.96.
Biotech drops again, pulling down market
Thursday, 10 April 2014 17:15
By MATTHEW CRAFT AP Business Writer NEW YORK (AP) - Biotech and Internet stocks tumbled again Thursday, and the broader market followed. After a two-day respite, investors again started dumping shares of cutting-edge drug companies and other industries that have soared over the past year. Biotechnology stocks have turned volatile in recent weeks as regulators scrutinize the cost of their drugs and investors worry their earnings won't justify lofty stock prices.
Stocks drop; Biotech takes another plunge
Thursday, 10 April 2014 13:00
By MATTHEW CRAFT AP Business Writer NEW YORK (AP) - Another plunge in the biotechnology sector led stock indexes down Thursday, as Biogen Idec, Gilead Sciences and other biotech companies extended a recent slump. EBay fell after Carl Icahn abandoned an effort to shake up the company and Bed Bath & Beyond fell after reporting weak sales figures. KEEPING SCORE: The Nasdaq composite index fell 111 points, or 2.7 percent, to 4,072 as of 1:45…
Stocks take another tumble; eBay heads lower
Thursday, 10 April 2014 11:45
By MATTHEW CRAFT AP Business Writer NEW YORK (AP) - U.S. stock indexes were drifting lower Thursday as investors picked over a mixed batch of corporate earnings reports. Biogen Idec, Gilead Sciences and other biotech companies extended their recent slump. KEEPING SCORE: The Standard & Poor's 500 index fel 11 points, or 0.6 percent, to 1,860 as of 11:20 p.m. Eastern time.
Value Investing And Dividend-Paying Bandwagons
Thursday, 10 April 2014 10:30
It seems that the financial press has warmed to the idea that investing in the kind of dividend-paying value stocks we favor at The Prudent Speculator is not a bad idea. With many heretofore high-flying, richly priced stocks having fallen back to earth, it was nice to see The Wall Street Journal penning columns over the last few days entitled Value Stocks Head Higher as Growth Companies Look Pricy and More Investors Are Drawn to…

Bayoubuzz.com provides this article only as a news aggregator, NOT as the publisher or as the author. After reading this small portion of the article, please click upon the ORIGINAL SOURCE link above and read the original article. Thank you.